Catalyst Wire Dossier Catalyst Wire Dossier

ALCAR

acetyl-L-carnitine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALCAR, covering 2016-08-24 to 2016-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma [Phase 2]

See pricing